From Wikipedia, the free encyclopedia. Footnotes and sources. Maximum effects vary widely depending on geneticsbody habitusageand status of gonad removal.
Reuters Health - Transgender women who take sex hormones to feminize their bodies may not experience as much breast development as they expect, a new European study suggests. For this type of transition, hormone therapy consists of both anti-androgens to block the activity of male sex hormones and curb male characteristics as well as estrogens to encourage breast development and feminization. Only 21 of the trans women attained a bra size of an A cup or larger after one year of hormone therapy, the study found.
Skip navigation! Story from Trans America. Estrogen is an important part of many transgender women's transition process. While not everyone feels that they need to be on hormones sometimes abbreviated to "mones"taking estrogen and testosterone-blocking medications can help transgender women create the body they want — one that aligns with their true gender.
Transgender hormone therapy of the male-to-female MTF type, also known as feminizing hormone therapyis hormone therapy and sex reassignment therapy to change the secondary sexual characteristics of transgender people from masculine or androgynous to feminine. Some intersex people also take this form of therapy, according to their personal needs and preferences. The purpose of the therapy is to cause the development of the secondary sex characteristics of the desired sexsuch as breasts and a feminine pattern of hairfatand muscle distribution.
In trans women male-to-female transsexual personscross-sex hormone therapy is administered to induce feminization. Breast development is an important part of feminization for most trans women. The aim of this study is to assess the effect of cross-sex hormone therapy on breast development in adult trans women.
Breast development happens in certain stages during a woman's life: first before birth, again at puberty, and later during the childbearing years. This starts with a thickening in the chest area called the mammary ridge or milk line. By the time a baby girl is born, nipples and the beginnings of the milk-duct system have formed.
Feminizing hormone therapy is used to induce physical changes in your body caused by female hormones during puberty secondary sex characteristics to promote the matching of your gender identity and your body gender congruence. If feminizing hormone therapy is started before the changes of male puberty begin, male secondary sex characteristics, such as increased body hair and changes in voice pitch, can be avoided. Feminizing hormone therapy is also referred to as cross-sex hormone therapy. During feminizing hormone therapy, you'll be given medication to block the action of the hormone testosterone.
Back to Gender dysphoria. Treatment for gender dysphoria aims to help people with the condition live the way they want to, in their preferred gender identity. What this means will vary from person to person, and is different for children, young people and adults.
The goals of feminizing hormone therapy are to raise the estrogen level and to lower the testosterone level so that both levels are in the normal, physiologic female range. There are three different kinds of medications that are typically used: estrogen, testosterone blockers, and progesterone. Estrogen is the hormone responsible for most feminine characteristics. It can be given as an oral pill, a patch on the skin, or an injection.